Next generation biomarkers for brain injury

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue SUPPL.2, 2013, Pages 44-49

  Serpero, Laura D ^a   Bellissima, Valentina ^a   Colivicchi, Micaela ^a   Sabatini, Miriam ^a   Frigiola, Alessandro ^b   Ricotti, Alberto ^a   Ghiglione, Valeria ^a   Strozzi, Maria C ^a   Li Volti, Giovanni ^b,c   Galvano, Fabio ^c   Gazzolo, Diego ^a,b  

^a C Arrigo Children's Hospital   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c GARIBALDI HOSPITAL   (Italy)

Author keywords

Activin A; Brain damage; Cardiovascular; G FAP; HO 1; NSE; Oxidative stress; S100B

Indexed keywords

ACTIVIN A; ADRENOMEDULLIN; AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; HEME OXYGENASE 1; NEURON SPECIFIC ENOLASE; PROTEIN S100B;

BRAIN INJURY; CALCIUM BINDING; CEREBROSPINAL FLUID; CHEMOLUMINESCENCE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERINATAL CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

ADRENOMEDULLIN; ASPHYXIA NEONATORUM; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; GLIAL FIBRILLARY ACIDIC PROTEIN; HEME OXYGENASE-1; HUMANS; INFANT, NEWBORN; OXIDATIVE STRESS; PHOSPHOPYRUVATE HYDRATASE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT;

EID: 84884652315     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.829688     Document Type: Review

References (89)

1. Abraha HD, Butterworth RJ, Bath PM, et al. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem 1997;34:366-70.
2. Rothoerl RD, Woertgen C, Holzschuh M, et al. S-100 serum levels after minor and major head injury. J Trauma 1998;45:765-7.
3. Raabe A, Seifert V. Fatal secondary increase in serum S-100B protein after severe head injury. Report of three cases. J Neurosurg 1999;91:875-7.
4. Woertgen C, Rothoerl RD, Metz C, Brawanski A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma 1999;47:1126-30.
5. Pleines UE, Morganti-Kossmann MC, Rancan M, et al. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma 2001;18:491-8.
6. Hayakata T, Shiozaki T, Tasaki O, et al. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 2004;22:102-7.
7. Savola O, Pyhtinen J, Leino TK, et al. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J Trauma 2004;56:1229-4.
8. Vos PE, Lamers KJ, Hendriks JC, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004;62:1303-10.
9. Foerch C, Singer OC, Neumann-Haefelin T, et al. Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol 2005;62:1130-4.
10. Sanchez-Pena P, Pereira AR, Sourour NA, et al. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med 2008;36:2267-73.
11. Moritz S, Schmidt C, Bucher M, et al. Neuromonitoring in carotid surgery: are the results obtained in awake patients transferable to patients under sevoflurane/fentanyl anesthesia? J Neurosurg Anesthesiol 2010;22:21-31.
12. Kovesdi E, Luckl J, Bukovics P, et al. Up-date on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochir (Wien) 2010;152:1-17.
13. Risso FM, Sannia A, Gazzolo D. Preterm and term newborn: primary investigations. J Matern Fetal Neonatal Med 2012;25: 70-2.
14. Hellström-Westas L, Rosén I. Continuous brain-function monitoring: state of the art in clinical practice. Semin Fetal Neonatal Med 2006;11:503-11.
15. Kochanek PM, Berger RP, Bayir H, et al. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: Diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr Opin Crit Care 2008;14:135-41.
16. Gazzolo D, Abella R, Frigiola A, et al. Neuromarkers and unconventional biological fluids. J Matern Fetal Neonatal Med 2010;23:66-9.
17. Florio P, Abella R, Marinoni E, et al. Biochemical markers of perinatal brain damage. Front Biosci (Schol Ed) 2010;2:47-72.
18. Gazzolo D, Abella R, Marinoni E, et al. New markers of neonatal neurology. J Matern Fetal Neonatal Med 2009;22:57-61.
19. Gazzolo D, Di Iorio R, Marinoni E, et al. S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage. Crit Care Med 2002;30:1356-60.
20. Gazzolo D, Bruschettini M, Lituania M, et al. Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. Clin Chem 2001;47:1836-8.
21. Gazzolo D, Marinoni E, Di Iorio R, et al. Urinary S100B protein measurements: a tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants. Crit Care Med 2004;32:131-6.
22. Gazzolo D, Marinoni E, Di Iorio R, et al. Measurement of urinary S100B protein concentrations for the early identification of brain damage in asphyxiated full-term infants. Arch Pediatr Adolesc Med 2003;157:1163-8.
23. Risso FM, Serpero LD, Zimmermann LJ, et al. Perinatal asphyxia: kidney failure does not affect S100B urine concentrations. Clin Chim Acta 2012;18:150-3.
24. Cullen VC, Fredenburg RA, Evans C, et al. Development and advanced validation of an optimized method for the quantitation of Ab42 in human cerebrospinal fluid. AAPS J 2012;14:510-8.
25. Koo J, Byun Y. Current status of PET-imaging probes of b-amyloid plaques. Arch Pharm Res 2013. [Epub ahead of print].
26. Apple FS, Jesse RL, Newby LK, et al. National Academy of Clinical Biochemistry; IFCC Committee for Standardization of Markers of Cardiac Damage. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes. Circulation 2007;115:e352-5.
27. Mulligan JC, Painter MJ, O'Donoghue PA, et al. Neonatal asphyxia II. Neonatal mortality and long-term sequelae. J Pediatr 1980;96: 903-7.
28. Low JA, Lindsay BG, Der-rick EJ. Threshold of metabolic acidosis associated with newborn complications. Am J Obstet Gynecol 1997;177:1391-4.
29. Gazzolo D, Michetti F. Perinatal S100B protein assessment in human unconventional biological fluids: a minireview and new perspectives. Cardiovasc Psychiatry Neurol 2010;2010:703563.
30. Ferri GL, Probert L, Cocchia D, et al. Evidence for the presence of S-100 protein in the glial component of the human enteric nervous system. Nature 1986;297:409-10.
31. Pham N, Fazio V, Cucullo L, et al. Extracranial sources of S100B do not affect serum levels. PLoS One. 2010;5(9). doi:pii: e12691. 10.1371/journal.pone. 0012691. Erratum in: PLoS One. 2010;5(10). doi: 10.1371/annotation/bdcb41f2- a320-4401-a6ab-86e71738597e. PubMed PMID: 20844757; PubMed Central PMCID: PMC2937027.
32. Blennow M, Savman K, Ilves P, et al. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta Paediatr 2001;90:1171-5.
33. Gazzolo D, Bruschettini M, Corvino V, et al. S100b protein concentrations in amniotic fluid correlate with gestational age and with cerebral ultrasound scanning results in healthy fetuses. Clin Chem 2001;47:954-6.
34. Gazzolo D, Vinesi P, Marinoni E, et al. S100B protein concentrations in cord blood: correlations with gestational age in term and preterm deliveries. Clin Chem 2000;46:998-1000.
35. Gazzolo D, Bruschettini M, Lituania M, et al. S100b protein concentrations in urine are correlated with gestational age in healthy preterm and term newborns. Clin Chem 2001;47: 1132-3.
36. Gazzolo D, Michetti F, Bruschettini M, et al. Pediatric concentrations of S100B protein in blood: age-and sex-related changes. Clin Chem 2003;49:967-70.
37. Gazzolo D, Lituania M, Bruschettini M, et al. S100B protein levels in saliva: correlation with gestational age in normal term and preterm newborns. Clin Biochem 2005;38:229-33.
38. Gazzolo D, Kornacka M, Bruschettini M, et al. Maternal glucocorticoid supplementation and S100B protein concentrations in cord blood and urine of preterm infants. Clin Chem 2003;4: 1215-8.
39. Sannia A, Risso FM, Serpero LD, et al. Antenatal glucocorticoid treatment affects preterm infants' S100B urine concentration in a dose-dependent manner. Clin Chim Acta 2010;411:1539-41.
40. Gazzolo D, Bruschettini M, Di Iorio R, et al. Maternal nitric oxide supplementation decreases cord blood S100B in intrauterine growth-retarded fetuses. Clin Chem 2002;48:647-50.
41. Gazzolo D, Florio P, Ciotti S, et al. S100B protein in urine of preterm newborns with ominous outcome. Pediatr Res 2005;58: 1170-4.
42. Gazzolo D, Frigiola A, Bashir M, et al. Diagnostic accuracy of S100B urinary testing at birth in full-term asphyxiated newborns to predict neonatal death. PLoS One 2009;4:e4298.
43. Florio P, Gazzolo D, Luisi S, et al. Activin A in brain injury. Adv Clin Chem 2007;43:117-33.
44. Florio P, Frigiola A, Battista R, et al. Activin A in asphyxiated full-term newborns with hypoxic ischemic encephalopathy. Front Biosci (Elite Ed) 2010;2:36-42.
45. Florio P, Luisi S, Bruschettini M, et al. Cerebrospinal fluid activin a measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy. Clin Chem 2004;50:2386-9.
46. Florio P, Luisi S, Moataza B, et al. High urinary concentrations of activin A in asphyxiated full-term newborns with moderate or severe hypoxic ischemic encephalopathy. Clin Chem 2007;53: 520-2.
47. Florio P, Perrone S, Luisi S, et al. Increased plasma concentrations of activin a predict intraventricular hemorrhage in preterm newborns. Clin Chem 2006;52:1516-21.
48. Sannia A, Zimmermann LJ, Gavilanes AW, et al. Elevated Activin A Urine Levels are Predictors of Intraventricular Hemorrhage in Preterm Newborns. Acta Paediatr 2013. [Epub ahead of print].
49. Luisi S, Calonaci G, Florio P, et al. Identification of activin A and follistatin in human milk. Growth Factors 2002;20:147-50.
50. Bellissima V, Ververs TF, Visser GH, Gazzolo D. Selective serotonin reuptake inhibitors in pregnancy. Curr Med Chem 2012;19:4554-61.
51. Bellissima V, Visser GH, Ververs TF, et al. Antenatal maternal antidepressants drugs affect Activin A concentrations in maternal blood, in amniotic fluid and in fetal cord blood. J Matern Fetal Neonatal Med 2011;24:31-4.
52. Di Iorio R, Marinoni E, Lituania M, et al. Adrenomedullin increases in term asphyxiated newborns developing intraventricular hemorrhage. Clin Biochem 2004;37:1112-6.
53. Di Iorio R, Marinoni E, Letizia C, et al. Adrenomedullin is increased in the fetoplacental circulation in intrauterine growth restriction with abnormal umbilical artery waveforms. Am J Obstet Gynecol 2000;182:650-4.
54. Gazzolo D, Marinoni E, Giovannini L, et al. Circulating adrenomedullin is increased in preterm newborns developing intraventricular hemorrhage. Pediatr Res 2001;50:544-7.
55. Di Iorio R, Marinoni E, Gazzolo D, et al. Maternal nitric oxide supplementation increases adrenomedullin concentrations in growth retarded fetuses. Gynecol Endocrinol 2002;16:187-92.
56. Florio P, Abella R, Marinoni E, et al. Adrenomedullin blood concentrations in infants subjected to cardiopulmonary bypass: correlation with monitoring parameters and prediction of poor neurological outcome. Clin Chem 2008;54:202-6.
57. Pahlman S, Esscher T, Bergvall P, Odelstad L. Purification and characterization of human neuron-specific enolase: radioimmuno-assay development. Tumour Biol 1984;5:127-39.
58. Basile AM, Fusi C, Conti AA, et al. S-100 protein and neuron-specific enolase as markers of subclinical cerebral damage after cardiac surgery: preliminary observation of a 6-month follow-up study. Eur Neurol 2001;45:151-9.
59. Fogel W, Krieger D, Veith M, et al. Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med 1997;25:1133-8.
60. Garcia-Alix A, Cabanas F, Pellicer A, et al. Neuron-specific enolase and myelin basic protein: relationship of cerebrospinal fluid concentrations to the neurologic condition of asphyxiated full-term infants. Pediatrics 1994;93:234-40.
61. Bracci R, Perrone S, Buonocore G. The timing of neonatal brain damage. Biol Neonate 2006;90:145-55.
62. Perrone S, Tataranno ML, Stazzoni G, Buonocore G. Biomarkers of oxidative stress in fetal and neonatal diseases. J Matern Fetal Neonatal Med 2012;25:2575-8.
63. Perrone S, Tataranno ML, Stazzoni G, et al. Oxidative injury in neonatal erythrocytes. J Matern Fetal Neonatal Med 2012;25: 104-8.
64. Buonocore G, Perrone S, Longini M, et al. Non protein bound iron as early predictive marker of neonatal brain damage. Brain 2003; 126:1224-30.
65. Gazzolo D, Perrone S, Paffetti P, et al. Non protein bound iron concentrations in amniotic fluid. Clin Biochem 2005;38: 674-7.
66. Foerch C, Curdt I, Yan B, et al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry 2006;77:181-4.
67. Blennow M, Rosengren L, Jonsson S, et al. Glial fibrillary acidic protein is increased in the cerebrospinal fluid of preterm infants with abnormal neurological findings. Acta Paediatr 1996; 85:485-9.
68. Ennen CS, Huisman TA, Savage WJ, et al. Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephal-opathy treated with whole-body cooling. Am J Obstet Gynecol 2011;205:251-7.
69. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 1968;61:748-55.
70. Bainbridge SA, Smith GN. HO in pregnancy. Free Radic Biol Med 2005;38:979-88.
71. Denschlag D, Marculescu R, Unfried G, et al. The size of a microsatellite polymorphism of the haem oxygenase 1 gene is associated with idiopathic recurrent miscarriage. Mol Hum Reprod 2004;10:211-4.
72. Shrestha Dangol D, Chen HP. Role of hemeoxygenase-2 in pregnancy-induced hypertension. Int J Gynaecol Obstet 2004;85: 44-6.
73. Eide IP, Isaksen CV, Salvesen KA, et al. Decidual expression and maternal serum levels of heme oxygenase 1 are increased in pre-eclampsia. Acta Obstet Gynecol Scand 2008;87:272-9.
74. Barber A, Robson SC, Myatt L, et al. Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction. FASEB J 2001;15:1158-68.
75. Tanaka Y, Maher JM, Chen C, Klaassen CD. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. Mol Pharmacol 2007;71:817-25.
76. Fujita T, Toda K, Karimova A, et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 2001;7:598-604.
77. Li Volti G, Galvano F, Frigiola A, et al. Potential immunoregu-latory role of heme oxygenase-1 in human milk: a combined biochemical and molecular modeling approach. J Nutr Biochem 2010;21:865-71.
78. Sannia A, Zimmermann LJ, Gavilanes AW, et al. S100B protein maternal and fetal bloodstreams gradient in healthy and small for gestational age pregnancies. Clin Chim Acta 2011;412: 1337-40.
79. Sannia A, Risso FM, Zimmermann LJ, et al. S100B urine concentrations in late preterm infants are gestational age and gender dependent. Clin Chim Acta 2013;417:31-4.
80. Gazzolo D, Frulio R, Roletti A, et al. S100A1B and S100BB urine levels in preterm and term healthy newborns. Clin Chim Acta 2007; 384:186-7.
81. Florio P, Marinoni E, Di Iorio R, et al. Urinary S100B protein concentrations are increased in intrauterine growth-retarded new-borns. Pediatrics 2006;118:e747-54.
82. Risso FM, Serpero LD, Zimmermann LJ, et al. Urine S100 BB and A1B dimers are valuable predictors of adverse outcome in full-term asphyxiated infants. Acta Paediatr 2013. [Epub ahead of print].
83. Florio P, Michetti F, Bruschettini M, et al. Amniotic fluid S100B protein in mid-gestation and intrauterine fetal death. Lancet 2004; 364:270-2.
84. Michetti F, Corvino V, Geloso MC, et al. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem 2012;120:644-59.
85. Risso FM, Sannia A, Gavilanes DA, et al. Biomarkers of brain damage in preterm infants. J Matern Fetal Neonatal Med 2012;25: 101-4.
86. Gazzolo D, Serpero LD, Frigiola A, et al. Antenatal glucocorticoids supplementation and central nervous system development. Curr Drug Metab 2013;14:160-6.
87. Atzori L, Antonucci R, Barberini L, et al. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci (Elite Ed) 2011;3:1005-12.
88. Dessì A, Atzori L, Noto A, et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med 2011;24:35-9.
89. Roka A, Kelen D, Halasz J, et al. Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia. Acta Paediatr 2012;101:319-23.